X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1648) 1648
Publication (83) 83
Newsletter (55) 55
Book Review (30) 30
Book Chapter (23) 23
Newspaper Article (10) 10
Magazine Article (7) 7
Dissertation (5) 5
Trade Publication Article (4) 4
Transcript (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cabergoline (1480) 1480
humans (868) 868
female (638) 638
index medicus (520) 520
male (479) 479
endocrinology & metabolism (452) 452
bromocriptine (422) 422
adult (418) 418
dopamine agonists - therapeutic use (385) 385
ergolines - therapeutic use (354) 354
middle aged (336) 336
hyperprolactinemia (307) 307
prolactin (296) 296
prolactinoma (291) 291
dopamine agonists (245) 245
pituitary neoplasms - drug therapy (236) 236
clinical neurology (223) 223
prolactinoma - drug therapy (223) 223
dopamine (205) 205
pregnancy (204) 204
aged (201) 201
treatment outcome (194) 194
dopamine agonist (182) 182
medicine & public health (182) 182
therapy (181) 181
animals (172) 172
prolactin - blood (167) 167
management (156) 156
parkinson's disease (133) 133
diagnosis (131) 131
ergolines - adverse effects (129) 129
parkinson disease - drug therapy (129) 129
dopamine agonists - adverse effects (127) 127
neurosciences (126) 126
pharmacology & pharmacy (124) 124
tumors (123) 123
cabergoline treatment (122) 122
pituitary-adenomas (120) 120
adolescent (111) 111
bromocriptine - therapeutic use (111) 111
care and treatment (111) 111
prolactinomas (111) 111
ergolines - administration & dosage (109) 109
magnetic resonance imaging (109) 109
pituitary neoplasms - pathology (109) 109
retrospective studies (107) 107
surgery (106) 106
hyperprolactinemia - drug therapy (105) 105
parkinsons-disease (105) 105
research (105) 105
obstetrics & gynecology (104) 104
ergolines - pharmacology (102) 102
endocrinology (100) 100
women (99) 99
pituitary neoplasms - complications (97) 97
young adult (96) 96
diabetes (91) 91
acromegaly (90) 90
prolactinoma - pathology (90) 90
dopamine agonists - administration & dosage (89) 89
pergolide (89) 89
medicine, general & internal (88) 88
prolactinoma - complications (87) 87
antineoplastic agents - therapeutic use (86) 86
health aspects (86) 86
pituitary (86) 86
pramipexole (85) 85
risk factors (84) 84
dopamine agonists - pharmacology (81) 81
levodopa (81) 81
expression (80) 80
follow-up (76) 76
long-term treatment (76) 76
dose-response relationship, drug (74) 74
medical research (74) 74
time factors (74) 74
reproductive biology (73) 73
pituitary neoplasms - surgery (72) 72
medicine, experimental (71) 71
pituitary adenoma (69) 69
pituitary neoplasms - diagnosis (69) 69
prevalence (69) 69
transsphenoidal surgery (69) 69
veterinary sciences (69) 69
internal medicine (68) 68
adenoma (67) 67
drug therapy (67) 67
ropinirole (67) 67
prolactinoma - diagnosis (66) 66
agonists (64) 64
analysis (64) 64
pituitary neoplasms - blood (63) 63
double-blind (61) 61
prolactinoma - blood (61) 61
valvular heart-disease (61) 61
pituitary neoplasms - therapy (60) 60
prolactinoma - surgery (60) 60
rats (60) 60
antiparkinson agents - therapeutic use (59) 59
neurology (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1615) 1615
French (36) 36
Spanish (30) 30
German (25) 25
Portuguese (10) 10
Japanese (9) 9
Russian (9) 9
Czech (3) 3
Italian (3) 3
Polish (3) 3
Korean (2) 2
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Der Gynakologe, ISSN 0017-5994, 07/2019, Volume 52, Issue 7, p. 529
Prolaktin unterliegt zahlreichen Einflussfaktoren und daher auch erheblichen Schwankungen, die Probleme bei der Interpretation und Ableitung diagnostischer... 
Prolactin | Cabergoline
Journal Article
Journal of Clinical and Diagnostic Research, ISSN 2249-782X, 08/2018, Volume 12, Issue 8, pp. QD03 - QD04
Journal Article
International Journal of Research in Pharmaceutical Sciences, 2018, Volume 9, Issue 1, pp. 243 - 248
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 03/2010, Volume 95, Issue 3, pp. 1025 - 1033
Context: An association has been demonstrated between valvular heart disease and dopamine agonist use in patients treated for Parkinson’s disease. Following... 
TERM CABERGOLINE THERAPY | LONG-TERM | DOSE CABERGOLINE | BROMOCRIPTINE TREATMENT | PLEUROPULMONARY DISEASE | ENDOCRINOLOGY & METABOLISM | INCREASED PREVALENCE | VALVULAR HEART-DISEASE | TRICUSPID REGURGITATION | PARKINSONS-DISEASE | DOPPLER-ECHOCARDIOGRAPHY
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 01/2018, Volume 240, Issue 1, pp. 1 - 13
To date, the management of dopamine agonist (DA)-resistant prolactinomas remains a major clinical problem. Previously, we determined that miRNA-93 expression... 
MiRNA-93 | Prolactinoma | Drug resistance | ATG7 | Autophagy | Cabergoline | ACTIVATION | prolactinoma | DOPAMINE D2 | DEATH | cabergoline autophagy | PATHWAY | INDUCED AUTOPHAGY | ENDOCRINOLOGY & METABOLISM | miRNA-93 | drug resistance | MULTIDRUG-RESISTANCE | RECEPTORS | EXPRESSION | PROMOTES | TUMORIGENESIS
Journal Article
Journal of Obstetrics and Gynaecology, ISSN 0144-3615, 07/2019, Volume 39, Issue 5, pp. 687 - 694
This study aimed to evaluate the effects of coasting, cabergoline and clarithromycin in a rat ovarian hyperstimulation syndrome (OHSS) model. The 42 female... 
Ovarian hyperstimulation syndrome | cabergoline | clarithromycin | coasting
Journal Article
Gynakologe, ISSN 0017-5994, 2019
Journal Article
World Neurosurgery, ISSN 1878-8750, 09/2019, Volume 129, pp. e686 - e694
First-line treatment for prolactin-producing pituitary adenomas is dopamine agonist (DA) therapy. This is the first study to analyze the rate of radiographic... 
Prolactinoma | Bromocriptine | Cabergoline | Dopamine agonist | Pituitary adenoma | SURGERY | DIAGNOSIS | MANAGEMENT | GUIDELINES | PREVALENCE | CABERGOLINE TREATMENT | SOCIETY | CLINICAL NEUROLOGY | PITUITARY-ADENOMAS | RESISTANT | MEDICAL THERAPY | Medical records | Dopamine | Prolactin
Journal Article
Journal Article
Медицинский совет, ISSN 2079-701X, 12/2016, Issue 12, pp. 156 - 160
Abnormal increase in prolactin hyperprolactinemia is one of the main signs of hypothalamic-pituitary-ovarian dysfunction. Consequently, the effect of dopamine... 
thyroiditis | hyperprolactinemia | cabergoline | breast
Journal Article
Hormone Research in Paediatrics, ISSN 1663-2818, 04/2018, Volume 89, Issue 3, pp. 157 - 165
Background: Paediatric prolactinomas are rare. The aim of this study was to investigate the clinical features and outcome of paediatric patients with... 
Original Paper | Prolactinoma | Children | Cabergoline | Hyperprolactinemia | Pituitary adenoma | MACROPROLACTINOMAS | BROMOCRIPTINE | CABERGOLINE THERAPY | SUPPRESSION | CHILDHOOD | ENDOCRINOLOGY & METABOLISM | TERM-FOLLOW-UP | PEDIATRICS | PEDIATRIC PITUITARY-ADENOMAS | WITHDRAWAL | MEN1
Journal Article
Endocrine Journal, ISSN 0918-8959, 2017
Although somatostatin analogues (SSAs) are recommended as the first-line medical therapy for acromegaly, dopamine agonists (DAs) are also a therapeutic option... 
Somatostatin analogues | Bromocriptine | Acromegaly | Dopamine agonists | Cabergoline
Journal Article
Gynecological Endocrinology, ISSN 0951-3590, 04/2019, Volume 35, Issue 4, pp. 287 - 289
Objective: Spontaneous ovarian hyperstimulation syndrome (SOHSS) is an extremely rare complication that deserves a multidisciplinary approach together with a... 
singleton pregnancy | cabergoline | Spontaneous ovarian hyperstimulation syndrome | pregnancy termination | STIMULATION | DOPAMINE AGONIST CABERGOLINE | TORSION | RECEPTOR | PREVENT | OBSTETRICS & GYNECOLOGY | ASSISTED REPRODUCTION | WOMEN | MUTATION | ENDOCRINOLOGY & METABOLISM
Journal Article
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, ISSN 1701-2163, 07/2019
This study sought to perform a systematic review of adverse events reported with the use of cabergoline for postpartum lactation inhibition or suppression in... 
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 03/2019, Volume 104, Issue 7, pp. 2527 - 2534
Context: Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known. Objective: To evaluate the... 
HYPERPROLACTINEMIA | CABERGOLINE | MEN | ENDOCRINOLOGY & METABOLISM | SYMPTOMS | PREVALENCE | HYPERSEXUALITY | PARKINSONS-DISEASE
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.